Work

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

Year: 2015

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(15)61137-0

Authors: Emmanuelle Le Page, David Veillard, David A Laplaud, Stéphanie Hamonic, Rasha Wardi, Christine Lebrun, Fabien Zagnoli, Sandrine Wiertlewski, Véronique Deburghgraeve, Marc Coustans, Gilles Edan

Institutions: Inserm, CIC Rennes, Centre Hospitalier Universitaire de Rennes, Laboratoire Traitement du Signal et de l'Image, Centre Hospitalier Universitaire de Nantes, Center for Research in Transplantation and Translational Immunology, Nantes Université, Centre Hospitalier de Saint-Brieuc, Centre Hospitalier Universitaire de Nice, Hôpital Pasteur, Hôpital d'Instruction des Armées Clermont-Tonnerre, Hôpital Laennec, Institut de Recherche en Informatique et Systèmes Aléatoires, Empenn

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W1908499568

FWCI: 13.52

Cites: 30

Cited by: 186

Related to: 10